Background and Purpose-The significance of asymptomatic coronary artery atherosclerosis burden (CAB) in the interpretation of stroke biomarker results is unknown. We investigated biomarker values to determine if they are related to cerebral atherosclerosis with consideration of CAB. Methods-We prospectively recruited patients with noncardioembolic ischemic cerebrovascular disease who had no history of coronary artery disease. Patient-based vascular assessment was conducted using MRA for the cerebral arteries and cardiac CT angiography for the coronary arteries. Biomarkers including the C-reactive protein and homocysteine were measured. Results-A total of 178 patients were included in the study. The extracranial carotid stenosis was associated with the highest quartile of C-reactive protein (OR, 2.24; 95% CI, 1.04 -4.55), whereas age was the only predictor of the highest quartile of homocysteine (OR, 1.06; 95% CI, 1.02-1.11). However, with consideration of CAB, CAB (Ն2 segments with Ն50% stenosis) remained the only independent predictor for the highest quartile of C-reactive protein (OR, 8.69; 95% CI, 2.41-31.30) and homocysteine (OR, 11.44; 95% CI, 2.61-50.11). Conclusions-Our data emphasize the importance of CAB in biomarker studies of patients with ischemic stroke. (Stroke.
Patients and Methods

Study Population
This prospective study analyzed consecutive patients admitted to a University Medical Center from September 2008 to March 2010. The inclusion criteria were having ischemic stroke or TIA, conducting cardiac computed tomography angiography (CCTA), having no history of coronary artery disease, and measuring CRP and/or homocysteine during hospitalization. We excluded patients who had potential sources of cardioembolism or other causes of stroke (nϭ32), chest pain, or discomfort before enrollment without a previous diagnostic work-up to rule out coronary artery disease (nϭ3), a history of myocardial infarction/angina (nϭ14), CCTA that could not be interpreted (nϭ3), and clinical signs of inflammatory or infectious disease (nϭ4). The local Institutional Review Board approved this study and all the patients gave their consent to participate in this study.
Stroke Work-Ups
All patients underwent brain MRI with diffusion-weighted imaging and MRA (cervical gadolinium-enhanced MRA and 3-dimensional time-of-flight MRA of circle of Willis). Cervicocephalic atherosclerosis was assessed using a standardized method. 1 Briefly, an investigator blinded to the clinical data and results of CCTA reviewed all available arterial investigations and assessed each arterial segment for the presence of cervicocephalic atherosclerosis. Each arterial segment was then classified as normal, Ͻ50% stenosis, or Ն50% stenosis. Cervicocephalic atherosclerosis load was categorized as no atherosclerosis or 1 segment with Ͻ50% stenosis, Ն2 segments with Ͻ50% stenosis, 1 segment with Ն50% stenosis, and Ն2 segments with Ն50% stenosis.
CCTA
CCTA was performed with the use of a 64-slice multidetector row CT scanner (Aquilion 64; Toshiba Medical Systems) or a dualsource CT system (Somatom Definition Flash; Siemens Medical Solutions). A standard scanning protocol was used, and radiation exposure was 4.0Ϯ3.7 mSv. All CCTA results were reviewed by a 
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single experienced radiologist blinded to the clinical data using a 3-dimensional workstation (Aquarius Workstation; TeraRecon). Each lesion was identified using the transverse images, the curved multiplanar reformations, and the volume-rendered images. The severity of the diameter stenosis was graded as normal, Ͻ50% stenosis, or Ն50% stenosis. CAB was categorized as no atherosclerosis or 1 segment with Ͻ50% stenosis (CAB1), Ն2 segments with Ͻ50% stenosis (CAB2), 1 segment with Ն50% stenosis (CAB3), and Ն2 segments with Ն50% stenosis (CAB4). 1
Results
A total of 178 patients met the inclusion criteria; there were 130 men and 48 women with a median age of 67 years (interquartile range, 59 -72; full range, 36 -86). Eighty-four percent had experienced ischemic stroke, whereas 16% had TIA. The baseline characteristics of the patients according to the quartiles of CRP and homocysteine are presented in Table 1 . Extracranial carotid stenosis, but not intracranial stenosis, was more frequently observed in patients with the highest quartile of CRP and homocysteine. Subjects in the highest quartile of homocysteine had a higher cervicocephalic atherosclerosis load and CAB and were significantly older than patients in the other quartiles. Gender, time interval from stroke onset to sample collection, vascular risk factors, previous medications, and lipid profiles did not differ between groups.
Factors independently associated with the highest quartile of CRP and homocysteine are shown in Table 2 . After adjusting for covariates, extracranial carotid stenosis was independently associated with the highest quartile of CRP (OR, 2.17; 95% CI, 1.07-4.37). However, in terms of homocysteine, age was the only predictor of subjects with the highest quartile of homocysteine.
Cervicocephalic vascular status was associated with coronary atherosclerosis (Supplementary Table I , http:// stroke.ahajournals.org). Both extracranial carotid (PϽ0.001) and intracranial (Pϭ0.023) stenosis were more prevalent, and cervicocephalic atherosclerosis load was higher (PϽ0.001) in patients with advanced coronary atherosclerosis (CAB 3-4). Patients had a higher quartile of the CRP (Pϭ0.010 for trends) and homocysteine (PϽ0.001 for trends) that was proportional to the increase in CAB (Table 1 and Supplementary Figure, http://stroke.ahajournals.org).
Based on these results, we performed multivariate logistic regression analysis while considering asymptomatic coronary atherosclerosis (Table 3) . After adjusting for covariates, CAB remained the only independent predictor for the highest quartile of biomarkers. Moreover, the risk for having the highest quartile of CRP and homocysteine was progressively higher with increasing CAB. The associations between cervicocephalic atherosclerosis and biomarkers lost their significance when CAB was considered.
Discussion
The 2 main findings of this study were: (1) the plasma levels of CRP and homocysteine were associated with the cervicocephalic atherosclerosis load and age in patients with noncardioembolic ischemic cerebrovascular disease; and (2) when asymptomatic CAB was considered, these associations lost significance. Asymptomatic CAB was the most important factor for elevated levels of both CRP and homocysteine, regardless of risk factor profiles and the degree and distribution of cervicocephalic atherosclerosis.
In the present study, extracranial carotid stenosis was the only determinant of the highest quartile of CRP in patients with ischemic cerebrovascular disease when CAB was not considered. Many studies have been conducted to evaluate the relationship between CRP and extracranial carotid atherosclerosis, but their results have not been consistent. Specifically, some investigators found that plasma levels of CRP were significantly elevated in patients with extracranial carotid atherosclerosis, 2 whereas other studies showed contradictory results. 3 Homocysteine has been suggested as a risk factor for atherosclerosis. 4 Several studies have evaluated the association between homocysteine and carotid atherosclerosis and their findings were inconsistent. 5 These results suggest that a more important factor that influences the levels of CRP and homocysteine is present.
There may be several reasons underlying the inconsistent association between stroke biomarkers and cervicocephalic atherosclerosis. First, ischemic cerebrovascular disease is a complex process that includes multiple etiologies. However, patients with cardioembolic stroke or other causes were excluded from the present study to preclude nonatheroscle- rotic occlusive disease. Second, atherosclerosis is a systemic disease. Coronary atherosclerosis may strongly influence the levels of stroke biomarkers. Although the levels of CRP predicted coronary artery disease, 6,7 CRP was not associated with the future risk of ischemic stroke in recent longitudinal studies. 8, 9 This lack of association between CRP and cervicocephalic atherosclerosis or stroke may be caused by various types of bias that make the magnitude of any independent association uncertain. 10 More importantly, the relationship between CRP and cervicocephalic atherosclerosis may be weaker than the association between CRP and coronary atherosclerosis, either asymptomatic or symptomatic (Supplementary Table II , http://stroke.ahajournals.org). Our findings provide new insights into the importance of burden (asymptomatic) of CAB in the interpretation of CRP and homocysteine data. The weakness of previous studies was that they did not take into account asymptomatic CAB as an explanatory factor of CRP and homocysteine levels. However, the reasons for importance of CAB over cervicocephalic atherosclerosis load on the levels of CRP and homocysteine are not clear. Although it is well-known that most coronary events are caused by plaque rupture and thrombosis, the frequency and degree of plaque rupture in ischemic cerebrovascular disease may be much lower and differ among sites of cervicocephalic vessels. A higher level of stroke biomarkers in a certain stroke subtype (eg, high CRP levels in extracranial carotid stenosis) may be caused by a high prevalence of CAB.
Our study has several limitations. First, this was a singlecenter study involving a modest sample size of Korean patients. Multicenter trials with larger cohorts and diverse races/ethnicities are needed. Second, we had only a single CRP and homocysteine measurement rather than several measures over time. However, most other studies that have been conducted to date have used a similar approach, and the time interval from symptom onset to sample collection was not different among groups stratified by CRP and homocysteine quartiles. Last, we have not assessed the presence of obstructive peripheral vascular disease, which may affect the levels of stroke biomarkers. However, a previous study showed the prevalence of obstructive peripheral vascular disease in patients with ischemic stroke is only Ϸ3% and is much lower in Asians. 11 In conclusion, CRP and homocysteine are associated with CAB, regardless of the characteristics of stroke or cerebral vascular status, even though we excluded the patients who had a history of coronary artery disease. These findings emphasize the importance of asymptomatic CAB in biomarker studies in patients with ischemic stroke. 
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